Consolidated management report as at 30 September 2022
Insider information as at 30 September 2022
Additional information as at 30 September 2022
Consolidated financial report according to BFSC standards as at 30 September 2022
Information according to Annex 4 of Ordinance 2 as at 30 September 2022
Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
Sofia, Bulgaria, 29 November 2022 – According to the requirements of Art. 100t of LPOS and in connection with Art. 114, para. 9 of the Law on Public Offering of Securities, “Sopharma” AD announces that today, according to a decision of the Board of Directors dated November 28, 2022, the company concluded the following transaction falling within the scope of Art. 114, para. 2 of the LPOS:
-
“Sopharma” AD as a Lessee, concluded Annex № 1 to the Lease Agreement dated March 1, 2022 with “Sopharma Imoti” REIT, UIC 175059266.
Declaration by the responsible directors as at 30 September 2022
Consolidated financial report according to IFRS as at 30 September 2022 - Excel
Tender offer to the shareholders of “Sopharma” AD by “Donev Investments Holding” AD
Sofia, Bulgaria, November 28, 2022 - According to the requirements of Art. 100t of the LPOS, the Board of Directors of "Sopharma" AD announces that on November 28, 2022, "Sopharma" AD received a tender offer registered with the Commission for Financial Supervision from "DONEV INVESTMENTS HOLDING" AD - a shareholder, directly owning 37,600,000 ordinary, dematerialized shares with voting rights, representing 27.89% of the capital and votes in the GMS of "SOPHARMA" AD, on the basis of Art.